doxazosin has been researched along with kmup 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chai, CY; Chen, IJ; Chou, YH; Huang, CH; Liu, CM; Lo, YC; Tai, MH; Wu, BN; Wu, WJ | 1 |
1 other study(ies) available for doxazosin and kmup 1
Article | Year |
---|---|
Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
Topics: Adrenergic alpha-Antagonists; Animals; bcl-2-Associated X Protein; Cell Division; Down-Regulation; Doxazosin; Enzyme-Linked Immunosorbent Assay; Humans; Male; Mice; Mice, Nude; Piperidines; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Xanthines | 2009 |